R3T@ 20mg

R3t@trut!de Peptide (GLP-1 / GIP / Glucagon Triple Agonist) – 20mg | ≥99% Purity

For laboratory research use only. Not for diagnostic, therapeutic, or human consumption.

R3t@trut!de is an advanced investigational peptide classified as a triple hormone receptor agonist, targeting:

• GLP-1 (Glucagon-Like Peptide-1) receptors
• GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors
• Glucagon receptors

This multi-receptor mechanism positions R3t@trut!de as one of the most promising research peptides in the study of obesity, metabolic disease, insulin resistance, and advanced weight regulation models.

By simultaneously activating incretin and glucagon signaling pathways, R3t@trut!de delivers a synergistic metabolic effect that extends beyond single-receptor peptides.

Triple Receptor Mechanism of Action

R3t@trut!de works by activating three key metabolic hormone receptors:

GLP-1 Receptor Activation

• Enhances insulin secretion
• Reduces appetite
• Improves glycemic control
• Slows gastric emptying

GIP Receptor Activation

• Amplifies insulin release
• Supports nutrient partitioning
• Enhances metabolic signaling

Glucagon Receptor Activation

• Increases energy expenditure
• Promotes fat oxidation
• Supports metabolic rate elevation

This triple-pathway activation allows researchers to evaluate both sides of the energy balance equation — reducing caloric intake while increasing caloric expenditure.

R3t@trut!de vs. Single or Dual Agonist Peptides

Unlike single GLP-1 receptor agonists such as Semaglutide or dual agonists like Tirzepatide, R3t@trut!de incorporates glucagon receptor stimulation, creating a broader metabolic impact.

Preclinical research models suggest this multi-receptor synergy may produce:

• Greater total body weight reduction
• Enhanced fat mass loss
• Improved insulin sensitivity
• Increased metabolic flexibility
• Superior lipid profile improvements

Key Research Applications of R3t@trut!de

• Appetite suppression and body weight reduction studies
• Insulin sensitivity and glucose regulation research
• Fat oxidation and metabolic rate enhancement models
• Liver fat reduction investigations
• Lipid metabolism and dyslipidemia studies
• Multi-pathway approaches to metabolic syndrome research
• Advanced obesity and type 2 diabetes research models

Its triple agonist classification makes R3t@trut!de especially valuable for research exploring comprehensive metabolic modulation.

Product Specifications

• Quantity: 20mg per vial
• Form: Lyophilized powder
• Purity: ≥99%
• Class: Triple receptor agonist peptide
• Molecular Weight: ~4.9 kDa (varies slightly based on salt form)
• CAS Number: Pending final registry (investigational research compound)

Storage & Handling

• Store the lyophilized R3t@trut!de peptide in a cool, dry, dark environment.
• Reconstitute with bacteriostatic water prior to research use.
• After reconstitution, refrigerate and use within the recommended research timeframe.

Sold per vial. Requires bacteriostatic water for reconstitution.
For laboratory research use only. Not for human consumption.